On Wednesday, ARM Holdings plc (ADR) (NASDAQ:ARMH)’s shares inclined 3.21% to $41.21.
ARM Holdings plc (ADR) (ARMH) has signed an expansive long-term graphics technology agreement with Samsung to enable the creation of next generation devices capable of delivering even more compelling visual experiences. The subscription license covers ARM® Mali™ graphics processing units (GPUs) counting the Mali-T820/830/860, the recently declared Mali-T880 and all future Mali GPUs.
This long term contract with ARM allows Samsung to continue creating innovative products addressing a range of price and performance points to meet the evolving needs of multiple markets. Samsung is already utilizing ARM Mali technology in SoCs powering an impressive range of leading consumer products.
ARM Holdings plc, together with its auxiliaries, designs microprocessors, physical intellectual property (IP), and related technology and software. The company also sells development tools that enhance the performance of embedded applications. Its products comprise microprocessor cores that comprise of specific functions, such as video, graphics, and display technology IP; and physical IP components for the design and manufacture of integrated circuits, which comprise embedded memory, standard cell, and input/output components.
Celgene Corporation (NASDAQ:CELG)’s shares gained 5.79% to $119.23.
Celgene Corporation (CELG) plans to present at three forthcoming investor conferences in September where Celgene administration will provide an overview of the Company. The conferences will be webcast live and a link to the webcast will be accessible in the Investor Relations section of the Company’s website at www.celgene.com.
Wednesday, September 9, 2015 at Baird’s 2015 Healthcare Conference in New York City at 3:45 pm ET
Wednesday, September 16, 2015 at the 2015 Morgan Stanley Global Healthcare Conference in New York City at 1:40 pm ET
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. It markets REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers; POMALYST/IMNOVID for the treatment of multiple myeloma; and VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, and chronic myelomonocytic leukemia, in addition to acute myeloid leukemia (AML).
At the end of Wednesday’s trade, Deere & Company (NYSE:DE)‘s shares surged 2.71% to $81.23.
Deere & Company (DE) reiterated its support for Trade Promotion Authority legislation passed recently by the U.S. Senate after earlier approval by the U.S. House of Representatives. It now moves to U.S. President Barack Obama, who is predictable to sign the bill into law.
TPA enables a U.S. President to submit projected trade agreement legislation to Congress for a yes or no vote, providing assurance to projected trading partners that the agreement will not be modified after negotiations have been accomplished.
Estimates state that more than one in five American jobs is supported by international trade. U.S. job growth from 2004 to 2013 was three times higher for trade-related jobs contrast with average job growth. In 2013, countries that have free-trade agreements with the U.S. purchased 12 times more goods per capita from the United States than those that don’t have such agreements.
Honeywell International Inc. (NYSE:HON), ended its Wednesday’s trading session with 4.16% gain, and closed at $97.84.
Honeywell (NYSE: HON) declared that Tim Mahoney, President and CEO, Honeywell Aerospace, will be presenting at the Gabelli & Company Aircraft Supplier Conference in New York City on Wednesday, September 9, 2015 from 8:30 – 9:00 a.m. EDT.
Honeywell International Inc. operates as a diversified technology and manufacturing company worldwide. Its Aerospace segment provides aircraft engines, integrated avionics, systems and service solutions, and related products and services for aircraft manufacturers and operators, airlines, military services, and defense and space contractors; and spare parts, and repair and maintenance services for the aftermarket.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
